Yawn, Barbara P
Suissa, Samy
Rossi, Andrea
Article History
Received: 15 September 2015
Revised: 11 July 2016
Accepted: 2 August 2016
First Online: 29 September 2016
Competing interests
: BPY serves on advisory boards for COPD for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck and Teva. She received research funding for COPD screening from Boehringer Ingelheim. SS has received research grants and participated in advisory board meetings and/or as a speaker at conferences for Actelion, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, Genentech and Novartis. AR has served on advisory boards for AstraZeneca, Boehringer Ingelheim and Novartis. He has received fees for lectures and support for participation in congresses from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Guidotti-Malesci, Menarini and Novartis. He has received support for research from Chiesi Farmaceutici and Novartis.